Document is current
Any future updates will be listed below
-
Authors
Bleckman, Roos F. https://orcid.org/0000-0001-6701-6208
Broekman, K. Esther
Roets, Evelyne
Mohammadi, Mohammed
Desar, Ingrid M. E.
Gelderblom, Hans
Mathijssen, Ron H. J.
Steeghs, Neeltje
de Graeff, Pauline
Reyners, Anna K. L.
-
Funding
Funding for this research was provided by:
Novartis
Pfizer
Bayer
Deciphera Pharmaceuticals
- License Information
-
More Information
Article History
Accepted: 21 November 2023
First Online: 20 December 2023
Declarations
:
: This study was funded by a research grant to the DGR, which was received from Novartis (3017/13), Pfizer (WI189378), Bayer (2013-MED-12005) and Deciphera (4EE9EEC-7F19-484D-86A4-646CFE0950A5).
: Roos F. Bleckman, K. Esther Broekman, Evelyne Roets, Mohammed Mohammadi, Ingrid M.E. Desar, Hans Gelderblom, Ron H.J. Mathijssen, Neeltje Steeghs, Pauline de Graeff and Anna .K.L. Reyners declare they have no conflicts of interest that might be relevant to the contents of this manuscript.
: This study was approved by local review boards of centers participating in the DGR.
: Not applicable.
: Not applicable.
: All data generated or analyzed during this study are included in this published article.
: Not applicable.
: RFB: Conceptualization, methodology, formal analysis, investigation, data curation, writing – original draft. KEB: Conceptualization, methodology, validation, formal analysis, investigation, writing – review and editing, supervision. ER: Data curation, writing – review and editing. MM: Data curation, writing – review and editing. IMED: Writing – review and editing. HG: Writing – review and editing. RHJM: Writing – review and editing. NS: Writing – review and editing. PdG: Conceptualization, methodology, validation, formal analysis, writing – review and editing, supervision. AKLR: Conceptualization, methodology, validation, formal analysis, writing – review and editing, supervision
